Skip to content

Synbiotic in Atopic Dermatitis in children

Effect of a new synbiotic mixture on atopic dermatitis in children

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
IRCT
Registry ID
IRCT201010204976N1
Enrollment
40
Registered
2011-02-09
Start date
2007-02-02
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic Dermatitis. infantile (acute)(chronic)

Interventions

Intervention 1: Participants were randomly divided into two groups. Intervention: Patients in the probiotic group received synbiotic containing 1 billion Colony Forming Unit(CFU) of Protexin Restore:
Treatment - Drugs
Participants were randomly divided into two groups. Intervention: Patients in the probiotic group received synbiotic containing 1 billion Colony Forming Unit(CFU) of Protexin Restore: a mixture of L
CONTROL: The control group received placebo powder without probiotics which were matched for size, shape, and volume of contents and manufactured by the same company, twice daily for 8 weeks

Sponsors

vice chancellor for research, Mashhad University of medical sciences.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 6 Years

Inclusion criteria

Inclusion criteria: Inclusion: Aged from 3 months to 6 years Mild to severe Atopic dermatitis Exclusion: Prior exposure to probiotics Were currently taking a course of antibiotics, or had other major medical problems

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of Atopic Dermatitis. Timepoint: At the beginning of the study, 2 months after intervention. Method of measurement: SCORAD method.

Secondary

MeasureTime frame
Cytokine profile(IL-4, INF- Gamma ). Timepoint: At the beginning of the study, 2 months after intervention. Method of measurement: ELISA on supernatant of Blood lymphocyte culture.

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026